American Healthcare REIT (NYSE:AHR) Price Target Raised to $27.00 at KeyCorp

American Healthcare REIT (NYSE:AHR) had its price target hoisted by equities researchers at KeyCorp from $16.00 to $27.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s price objective suggests a potential upside of 11.16% from the stock’s current price.

A number of other analysts have also weighed in on AHR. Bank of America increased their price objective on shares of American Healthcare REIT from $19.00 to $27.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Truist Financial increased their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. JMP Securities increased their price objective on shares of American Healthcare REIT from $16.00 to $18.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 7th. Finally, Morgan Stanley increased their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, August 22nd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and a consensus price target of $20.38.

American Healthcare REIT Trading Down 0.4 %

Shares of NYSE:AHR opened at $24.29 on Monday. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT has a 12 month low of $12.63 and a 12 month high of $25.10. The company has a 50-day moving average price of $18.87 and a 200 day moving average price of $15.84.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.28). American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The firm had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $506.55 million. American Healthcare REIT’s quarterly revenue was up 7.9% on a year-over-year basis. As a group, research analysts expect that American Healthcare REIT will post 1.28 EPS for the current fiscal year.

Hedge Funds Weigh In On American Healthcare REIT

A number of institutional investors have recently modified their holdings of AHR. Principal Financial Group Inc. purchased a new position in American Healthcare REIT during the first quarter valued at approximately $88,504,000. Centersquare Investment Management LLC purchased a new position in American Healthcare REIT during the first quarter valued at approximately $63,269,000. V3 Capital Management L.P. purchased a new position in American Healthcare REIT during the first quarter valued at approximately $42,337,000. Goldentree Asset Management LP purchased a new position in American Healthcare REIT during the first quarter valued at approximately $22,125,000. Finally, Russell Investments Group Ltd. purchased a new position in American Healthcare REIT during the first quarter valued at approximately $20,381,000. 16.68% of the stock is owned by hedge funds and other institutional investors.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.